Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL®platform

Microarray platform consistency is revealed by biologically functional analysis of gene expression profiles

(2009) Zhiguang Li et al.   BMC BIOINFORMATICS

Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer

(2009) Jeremy Chien et al.   GYNECOLOGIC ONCOLOGY

Gene-Expression Signatures in Breast Cancer

(2009) Christos Sotiriou et al.   NEW ENGLAND JOURNAL OF MEDICINE

Whole-Genome Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissue Samples

(2009) Craig April et al.   PLoS One

Generation of a non-small cell lung cancer transcriptome microarray

(2008) Austin Tanney et al.   BMC Medical Genomics

Gene Expression Signatures, Clinicopathological Features, and Individualized Therapy in Breast Cancer

(2008) Chaitanya R. Acharya   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The genomic profile ofHER2-amplified breast cancers: the influence of ER status

(2008) C Marchiò et al.   JOURNAL OF PATHOLOGY

Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays

(2008) Maria Ravo et al.   LABORATORY INVESTIGATION

The role of molecular analysis in breast cancer

(2008) Felipe C. Geyer et al.   PATHOLOGY

A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy

(2008) Tohru Nakagawa et al.   PLoS One